Breaking News Instant updates and real-time market news.

2023-02-03 07:42:10 FTHWF Field Trip Health / + 07:42 02/03/23 02/03 07:42 02/03/23 07:42	Field Trip Health announces posting on the OTC Market Field Trip Health & Wellness has received approval from the Financial Regulatory Authority for its shares to commence trading on the OTCQB Market in the United States under the symbol "FTHWF" effective February 2, 2023. Field Trip will continue to trade on the TSX Venture Exchange under its existing symbol "FTHW". The Company also announced that as a result, in part, of the announcement by the US government of its intention to end the Public Health Emergency related to the COVID-19 Pandemic, it is re-evaluating its Freedom by Field Trip program. The Freedom by Field Trip program relies on an exception to the Ryan Haight Act that permitted prescribing of controlled substances such as ketamine by telemedicine during the PHE. With the end of the PHE occurring in the first half of 2023, the Company is evaluating its strategy around the Freedom by Field Trip program and, as a result, has stopped enrolling new clients in the program.

2023-02-03 07:42:10

FTHWF

Field Trip Health

/ +

07:42

02/03/23

02/03

07:42

02/03/23

07:42

Field Trip Health announces posting on the OTC Market

Field Trip Health & Wellness has received approval from the Financial Regulatory Authority for its shares to commence trading on the OTCQB Market in the United States under the symbol "FTHWF" effective February 2, 2023. Field Trip will continue to trade on the TSX Venture Exchange under its existing symbol "FTHW". The Company also announced that as a result, in part, of the announcement by the US government of its intention to end the Public Health Emergency related to the COVID-19 Pandemic, it is re-evaluating its Freedom by Field Trip program. The Freedom by Field Trip program relies on an exception to the Ryan Haight Act that permitted prescribing of controlled substances such as ketamine by telemedicine during the PHE. With the end of the PHE occurring in the first half of 2023, the Company is evaluating its strategy around the Freedom by Field Trip program and, as a result, has stopped enrolling new clients in the program.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Aurora Cannabis announces Nasdaq notice of non-compliance » 18:02 03/24/23 03/24 18:02 03/24/23 18:02 ACB Aurora Cannabis / + Aurora Cannabis announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options ACB Aurora Cannabis / + 02/22/23 Aurora Cannabis and MedReleaf Australia to launch CraftPlant brand 01/04/23 Aurora Cannabis sells Aurora Polaris facility for $15M 12/05/22 Aurora Cannabis repurchases $76.1M of convertible senior notes 12/02/22 White House announces signing of medical marijuana research expansion act ACB Aurora Cannabis / + 02/13/23 CIBC Aurora Cannabis price target lowered to C$1.75 from C$2.25 at CIBC 02/10/23 Canaccord Aurora Cannabis price target lowered to C$1.50 from C$2 at Canaccord 02/10/23 Canaccord Aurora Cannabis price target lowered to C$1.50 from C$2.00 at Canaccord 01/27/23 Stifel Aurora Cannabis price target lowered to C$1.45 from C$1.75 at Stifel ACB Aurora Cannabis / + 02/09/23 Aurora Cannabis reports Q2 adjusted EBITDA C$1.4M vs. (C$7.1M) a year ago 02/09/23 Aurora Cannabis reports Q2 revenue C$61.7M vs. C$60.6M a year ago 11/10/22 Aurora Cannabis sees adjusted EBITDA profitability by December 31 11/10/22 Aurora Cannabis reports Q1 revenue C$49.3M, consensus C$52.5M 27 May ACB Aurora Cannabis / + 12/27/22 FDA explores regulating CBD in foods, supplements, WSJ reports 12/05/22 Defense bill with marijuana reform attached is delayed, Marijuana Moment says ACB Aurora Cannabis / + 03/23/23 Here's What You Missed in Cannabis, Psychedelics This Week 03/16/23 Rising High: Exclusive talk with house of brands Carma HoldCo 03/09/23 Rising High: Exclusive talk with cannabinoid market research firm BDSA 03/02/23 Rising High: Exclusive talk with vertically-integrated MSO Greenlight ACB Aurora Cannabis / + 08:45 Today Largest borrow rate increases among liquid names 03/07/23 Largest borrow rate increases among liquid names 03/02/23 Largest borrow rate increases among liquid names 02/16/23 Largest borrow rate increases among liquid names
Earnings	PPL Corp. backs FY23 EPS view $1.50-$1.65, consensus $1.59 » 17:43 03/24/23 03/24 17:43 03/24/23 17:43 PPL PPL Corp. $26.79 / +0.85 (+3.28%) The company still… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events PPL PPL Corp. $26.79 / +0.85 (+3.28%) 02/17/23 PPL Corp. reaffirms $12B of planned infrastructure investments from 2023-2026 02/17/23 PPL Corp. raises quarterly dividend to 24c from 22.5c per share 01/24/23 PPL Corp. trading resumes 01/24/23 PPL Corp. trading halted, volatility trading pause PPL PPL Corp. $26.79 / +0.85 (+3.28%) 03/20/23 Mizuho PPL Corp. price target lowered to $28 from $32 at Mizuho 01/18/23 Barclays PPL Corp. initiated with an Equal Weight at Barclays 01/12/23 Mizuho PPL Corp. price target raised to $32 from $30 at Mizuho 12/15/22 Morgan Stanley PPL Corp. upgraded to Overweight from Equal Weight at Morgan Stanley PPL PPL Corp. $26.79 / +0.85 (+3.28%) 02/17/23 PPL Corp. backs FY23 EPS view $1.50-$1.65, consensus $1.59 02/17/23 PPL Corp. reports Q4 adjusted EPS 28c, consensus 28c 01/11/23 PPL sees FY23 EPS $1.50-$1.65, consensus $1.59 11/04/22 PPL narrows FY22 EPS view to $1.35-$1.45 from $1.30-$1.45 PPL PPL Corp. $26.79 / +0.85 (+3.28%) 01/11/23 Ellliott has built 'top 10' stake in PPL Corp., Bloomberg says 01/11/23 Ellliott has built 'top 10' stake in PPL Corp., Bloomberg says PPL PPL Corp. $26.79 / +0.85 (+3.28%) 01/11/23 What You Missed On Wall Street On Wednesday 05/17/23 PPL Corp.
Conference/Events	Jefferies Euro Midcaps analyst to hold an analyst/industry conference call » 17:25 03/24/23 03/24 17:25 03/24/23 17:25 European Midcaps Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Cutera receives Nasdaq notification of deficiency » 17:16 03/24/23 03/24 17:16 03/24/23 17:16 CUTR Cutera $27.06 / +1.34 (+5.21%) Cutera announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly CUTR Cutera $27.06 / +1.34 (+5.21%) 03/01/23 Cutera delays release of 10-K due to 'material weakness' in internal control 12/01/22 Cutera responds to FDA inquiry CUTR Cutera $27.06 / +1.34 (+5.21%) 03/01/23 Maxim Cutera price target lowered to $50 from $55 at Maxim 01/31/23 William Blair Cutera initiated with a Market Perform at William Blair 01/12/23 Maxim Cutera price target lowered to $55 from $80 at Maxim 01/11/23 Cantor Fitzgerald Cutera downgraded to Neutral from Overweight at Cantor Fitzgerald CUTR Cutera $27.06 / +1.34 (+5.21%) 02/28/23 Cutera sees FY23 revenue $277M-$292M, consensus $300.7M 02/28/23 Cutera reports Q4 EPS (40c), consensus (24c) 01/09/23 Cutera sees FY22 revenue view $252M-$253M, consensus $259M 11/03/22 Cutera reports Q3 EPS (62c), consensus (30c) CUTR Cutera $27.06 / +1.34 (+5.21%) 02/28/23 Fly Intel: After-Hours Movers 01/09/23 What You Missed On Wall Street On Monday 01/09/23 What You Missed On Wall Street This Morning 12/08/22 What You Missed On Wall Street On Thursday
Conference/Events	Sherwin-Williams management to meet with Mizuho » 17:15 03/24/23 03/24 17:15 03/24/23 17:15 SHW Sherwin-Williams $211.39 / +2.355 (+1.13%) Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SHW Sherwin-Williams $211.39 / +2.355 (+1.13%) 01/26/23 Sherwin-Williams: 2023 base case remains to 'prepare for the worst' 01/26/23 Sherwin-Williams falls -10.7% 11/08/22 Sherwin-Williams to acquire Oskar Nolte GmbH, Klumpp Coatings GmbH 10/25/22 Sherwin-Williams jumps 5% to $223.00 after Q3 results beat estimates SHW Sherwin-Williams $211.39 / +2.355 (+1.13%) 02/08/23 KeyBanc Sherwin-Williams downgraded to Sector Weight from Overweight at KeyBanc 01/31/23 RBC Capital Sherwin-Williams price target lowered to $267 from $285 at RBC Capital 01/30/23 Barclays Sherwin-Williams price target lowered to $220 from $245 at Barclays 01/27/23 BMO Capital Sherwin-Williams price target lowered to $231 from $283 at BMO Capital SHW Sherwin-Williams $211.39 / +2.355 (+1.13%) 01/26/23 Sherwin-Williams sees Q1 revenue growth flat to up in mid-single digits 01/26/23 Sherwin-Williams sees FY23 adjusted EPS $7.95-$8.65, consensus $10.14 01/26/23 Sherwin-Williams reports Q4 adjusted EPS $1.89, consensus $1.86 01/25/23 Notable companies reporting before tomorrow's open SHW Sherwin-Williams $211.39 / +2.355 (+1.13%) 02/08/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/26/23 What You Missed On Wall Street On Thursday 01/26/23 What You Missed On Wall Street This Morning 01/26/23 Fly Intel: Pre-market Movers 03/30/23 Sherwin-Williams 04/19/23 The Sherwin-Williams Company 06/05/23 Sherwin-Williams
Hot Stocks	Berkshire Grey trading resumes 17:15 03/24/23 03/24 17:15 03/24/23 17:15 BGRY Berkshire Grey $1.14 / -0.055 (-4.60%) ShowHide Related Items >><< Company News Street Research Earnings BGRY Berkshire Grey $1.14 / -0.055 (-4.60%) 16:48 Today Berkshire Grey enters merger agreement with SoftBank Group 16:40 Today Berkshire Grey trading halted, news pending 02/10/23 Berkshire Grey confirms receipt of indication of interest from SoftBank Group 01/26/23 Berkshire Grey and Locus Robotics team on cross-platform robotic automation BGRY Berkshire Grey $1.14 / -0.055 (-4.60%) 08/02/22 Craig-Hallum Berkshire Grey pact with FedEx 'significant catalyst,' says Craig-Hallum 03/30/22 Craig-Hallum Berkshire Grey price target lowered to $8 from $15 at Craig-Hallum BGRY Berkshire Grey $1.14 / -0.055 (-4.60%) 11/14/22 Berkshire Grey lowers FY22 revenue view to $65M-$70M from $70M-$80M 11/14/22 Berkshire Grey reports Q3 EPS (11c), consensus (13c)
Conference/Events	Cigna management to meet with Mizuho » 17:14 03/24/23 03/24 17:14 03/24/23 17:14 CI Cigna $260.20 / +3.75 (+1.46%) Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CI Cigna $260.20 / +3.75 (+1.46%) 02/28/23 Cigna CEO sells $5.92M in common stock 02/02/23 Managed care stocks pressured after CMS' preliminary Medicare Advantage rates 01/12/23 California AG files suit against drugmakers, PBMs over insulin prices 12/06/22 Walmart to pay $500,000 over workers' compensation prescription procedures CI Cigna $260.20 / +3.75 (+1.46%) 02/23/23 JPMorgan Cigna price target lowered to $370 from $378 at JPMorgan 02/08/23 Deutsche Bank Cigna price target lowered to $348 from $359 at Deutsche Bank 02/08/23 SVB Securities Cigna price target lowered to $309 from $335 at SVB Securities 02/06/23 Loop Capital Cigna price target lowered to $320 from $350 at Loop Capital CI Cigna $260.20 / +3.75 (+1.46%) 02/03/23 Cigna sees FY23 adjusted EPS $24.60, consensus $24.84 02/03/23 Cigna reports Q4 adjusted EPS $4.96, consensus $4.86 02/02/23 Notable companies reporting before tomorrow's open 02/02/23 Notable companies reporting before tomorrow's open CI Cigna $260.20 / +3.75 (+1.46%) 01/27/23 Cigna sues CVS Health, Amy Bricker for violating noncompete, Bloomberg Law says 11/29/22 Managed care company returns will be tough to keep replicating, WSJ says 11/07/22 Walgreens-backed VillageMD close to $9B deal with Summit, WSJ reports CI Cigna $260.20 / +3.75 (+1.46%) 02/03/23 What You Missed On Wall Street On Friday 02/03/23 What You Missed On Wall Street This Morning 02/03/23 Fly Intel: Pre-market Movers 01/27/23 What You Missed On Wall Street This Morning 05/05/23 Cigna - CI 03/28/23 Cigna 03/29/23 Cigna 04/26/23 Cigna Group (The) CI Cigna $260.20 / +3.75 (+1.46%) 01/13/23 Early notable gainers among liquid option names on January 13th
General news	Treasury Market Summary: » 17:10 03/24/23 03/24 17:10 03/24/23 17:10 $ECON Economic Data / + Treasury Market Summary:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Technical Analysis $ECON Economic Data / + 03/22/23 Senators Scott, Warren unveil bipartisan Fed oversight legislation 03/01/23 Einhorn says investors should be 'bearish on stocks and bullish on inflation' $ECON Economic Data / + $ECON Economic Data / + 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/07/23 Powell tells Congress data from January partly reversed softening trends 01/30/23 Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says $ECON Economic Data / + 03/22/23 What You Missed On Wall Street On Wednesday 03/21/23 What You Missed On Wall Street On Tuesday 03/21/23 What You Missed On Wall Street This Morning 03/08/23 What You Missed On Wall Street On Wednesday $ECON Economic Data / + 03/22/23 Fed says 'additional policy firming may be appropriate'
Syndicate	Intercept files automatic mixed securities shelf 17:03 03/24/23 03/24 17:03 03/24/23 17:03 ICPT Intercept $13.47 / -0.19 (-1.39%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ICPT Intercept $13.47 / -0.19 (-1.39%) 03/10/23 Intercept announces GIDAC meeting on OCA scheduled for May 19 03/02/23 Intercept sees FY23 Ocaliva net sales $310M-$340M 01/19/23 FDA accepts Intercept NDA for OCA to treat NASH pre-cirrhotic liver fibrosis 01/04/23 Intercept announcse efficacy, safety data from Phase 3 REGENERATE study ICPT Intercept $13.47 / -0.19 (-1.39%) 03/05/23 Raymond James Intercept price target raised to $28 from $26 at Raymond James 03/03/23 SVB Securities Intercept price target raised to $18 from $17 at SVB Securities 03/03/23 RBC Capital Intercept price target raised to $19 from $17 at RBC Capital 02/15/23 RBC Capital Intercept price target raised to $18 from $15 at RBC Capital ICPT Intercept $13.47 / -0.19 (-1.39%) 03/02/23 Intercept reports Q4 EPS (50c), consensus (16c) 01/11/23 Intercept sees FY22 net sales of $343M, up 10% y/y 11/01/22 Intercept sees 2022 Ocaliva adjusted net sales $340M-$350M 11/01/22 Intercept reports Q3 EPS $7.80, consensus $4.61 ICPT Intercept $13.47 / -0.19 (-1.39%) 12/19/22 Trial success is rocketing this NASH stock higher and sinking these peers 09/30/22 What You Missed On Wall Street On Friday 09/30/22 What You Missed On Wall Street This Morning 09/30/22 Fly Intel: Pre-market Movers 04/18/23 Pharmaceuticals 04/18/23 Intercept - ICPT 05/19/23 Gastrointestinal Drugs Advisory Committee Virtual Meeting 06/22/23 PDUFA Date for OCA
Syndicate	Checkpoint Therapeutics files automatic mixed securities shelf 17:03 03/24/23 03/24 17:03 03/24/23 17:03 CKPT Checkpoint Therapeutics $3.68 / +0.09 (+2.51%) ShowHide Related Items >><< Company News Street Research On The Fly CKPT Checkpoint Therapeutics $3.68 / +0.09 (+2.51%) 03/02/23 Checkpoint Therapeutics announces FDA filing acceptance of BLA for cosibelimab 01/04/23 Checkpoint Therapeutics submits BLA to FDA for cosibelimab 01/03/23 Checkpoint Therapeutics trading resumes 01/03/23 Checkpoint Therapeutics trading halted, volatility trading pause CKPT Checkpoint Therapeutics $3.68 / +0.09 (+2.51%) 03/02/23 Lake Street Checkpoint Therapeutics price target lowered to $32 from $41 at Lake Street 01/05/23 Lake Street Checkpoint Therapeutics price target adjusted to $41 at Lake Street after split 01/04/23 H.C. Wainwright Checkpoint filing starts 'transformative shift,' says H.C. Wainwright 01/04/23 Cantor Fitzgerald Checkpoint Therapeutics' BLA submission positive news, says Cantor Fitzgerald CKPT Checkpoint Therapeutics $3.68 / +0.09 (+2.51%) 12/08/22 Biotech Alert: Searches spiking for these stocks today 11/09/22 Biotech Alert: Searches spiking for these stocks today

General news	Treasury readout from FSOC: "the U.S. banking system remains sound and resilient." » 16:55 03/24/23 03/24 16:55 03/24/23 16:55 $ECON Economic Data / + Treasury readout from… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Technical Analysis $ECON Economic Data / + 03/22/23 Senators Scott, Warren unveil bipartisan Fed oversight legislation 03/01/23 Einhorn says investors should be 'bearish on stocks and bullish on inflation' $ECON Economic Data / + $ECON Economic Data / + 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/07/23 Powell tells Congress data from January partly reversed softening trends 01/30/23 Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says $ECON Economic Data / + 03/22/23 What You Missed On Wall Street On Wednesday 03/21/23 What You Missed On Wall Street On Tuesday 03/21/23 What You Missed On Wall Street This Morning 03/08/23 What You Missed On Wall Street On Wednesday $ECON Economic Data / + 03/22/23 Fed says 'additional policy firming may be appropriate'
Syndicate	Eagle Bulk Shipping files to sell 3.78M shares of common stock for holders 16:54 03/24/23 03/24 16:54 03/24/23 16:54 EGLE Eagle Bulk Shipping $47.59 / +0.85 (+1.82%) ShowHide Related Items >><< Company News Street Research Earnings EGLE Eagle Bulk Shipping $47.59 / +0.85 (+1.82%) 03/03/23 Eagle Bulk Shipping falls -15.0% 03/03/23 Eagle Bulk Shipping falls -11.7% 03/03/23 Eagle Bulk Shipping falls -11.4% 01/19/23 Eagle Bulk Shipping appoints Kate Blankenship to board EGLE Eagle Bulk Shipping $47.59 / +0.85 (+1.82%) 01/30/23 Fearnley Eagle Bulk Shipping upgraded to Buy from Hold at Fearnley 01/23/23 BTIG Eagle Bulk Shipping price target raised to $70 from $60 at BTIG 10/10/22 B. Riley Eagle Bulk Shipping price target lowered to $72 from $82 at B. Riley 09/29/22 Stifel Eagle Bulk Shipping initiated with a Buy at Stifel EGLE Eagle Bulk Shipping $47.59 / +0.85 (+1.82%) 03/02/23 Eagle Bulk Shipping reports Q4 adjusted EPS $2.76, consensus $2.99 11/03/22 Eagle Bulk Shipping reports Q3 adjusted EPS $4.58, consensus $4.70
Syndicate	Eagle Bulk Shipping files $750M mixed securities shelf 16:54 03/24/23 03/24 16:54 03/24/23 16:54 EGLE Eagle Bulk Shipping $47.59 / +0.85 (+1.82%) ShowHide Related Items >><< Company News Street Research Earnings EGLE Eagle Bulk Shipping $47.59 / +0.85 (+1.82%) 03/03/23 Eagle Bulk Shipping falls -15.0% 03/03/23 Eagle Bulk Shipping falls -11.7% 03/03/23 Eagle Bulk Shipping falls -11.4% 01/19/23 Eagle Bulk Shipping appoints Kate Blankenship to board EGLE Eagle Bulk Shipping $47.59 / +0.85 (+1.82%) 01/30/23 Fearnley Eagle Bulk Shipping upgraded to Buy from Hold at Fearnley 01/23/23 BTIG Eagle Bulk Shipping price target raised to $70 from $60 at BTIG 10/10/22 B. Riley Eagle Bulk Shipping price target lowered to $72 from $82 at B. Riley 09/29/22 Stifel Eagle Bulk Shipping initiated with a Buy at Stifel EGLE Eagle Bulk Shipping $47.59 / +0.85 (+1.82%) 03/02/23 Eagle Bulk Shipping reports Q4 adjusted EPS $2.76, consensus $2.99 11/03/22 Eagle Bulk Shipping reports Q3 adjusted EPS $4.58, consensus $4.70
Hot Stocks	Coffee Holding receives Nasdaq notice over delayed annual report » 16:53 03/24/23 03/24 16:53 03/24/23 16:53 JVA Coffee Holding $1.82 / -0.02 (-1.09%) Coffee Holding Co.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News JVA Coffee Holding $1.82 / -0.02 (-1.09%) 02/06/23 Coffee Holding receives non-compliance letter from Nasdaq 09/30/22 Coffee Holding trading resumes 09/30/22 Delta Corp enters merger, share exchange agreement with Coffee Holdings 09/30/22 Coffee Holding trading halted, news pending
Hot Stocks	Berkshire Grey enters merger agreement with SoftBank Group » 16:48 03/24/23 03/24 16:48 03/24/23 16:48 BGRY Berkshire Grey $1.14 / -0.055 (-4.60%) , SFTBY SoftBank Group $18.93 / +0.1 (+0.53%) Berkshire Grey (BGRY)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly BGRY SFTBY BGRY Berkshire Grey $1.14 / -0.055 (-4.60%) 16:40 Today Berkshire Grey trading halted, news pending 02/10/23 Berkshire Grey confirms receipt of indication of interest from SoftBank Group 01/26/23 Berkshire Grey and Locus Robotics team on cross-platform robotic automation 10/05/22 Berkshire Grey enters $75M equity purchase agreement with Lincoln Park Capital SFTBY SoftBank Group $18.93 / +0.1 (+0.53%) 03/17/23 WeWork says agreements result in funding and capital commitments of over $1B 03/05/23 Fly Intel: Top five weekend stock stories 02/10/23 Berkshire Grey confirms receipt of indication of interest from SoftBank Group BGRY SFTBY BGRY Berkshire Grey $1.14 / -0.055 (-4.60%) 08/02/22 Craig-Hallum Berkshire Grey pact with FedEx 'significant catalyst,' says Craig-Hallum 03/30/22 Craig-Hallum Berkshire Grey price target lowered to $8 from $15 at Craig-Hallum SFTBY SoftBank Group $18.93 / +0.1 (+0.53%) 02/28/23 Jefferies SoftBank Group upgraded to Hold from Underperform at Jefferies 12/06/22 JPMorgan SoftBank Group downgraded to Neutral from Overweight at JPMorgan 11/29/22 Citi SoftBank Group downgraded to Neutral from Buy at Citi 11/14/22 Jefferies SoftBank Group downgraded to Underperform from Hold at Jefferies BGRY BGRY Berkshire Grey $1.14 / -0.055 (-4.60%) 11/14/22 Berkshire Grey lowers FY22 revenue view to $65M-$70M from $70M-$80M 11/14/22 Berkshire Grey reports Q3 EPS (11c), consensus (13c) SFTBY SFTBY SoftBank Group $18.93 / +0.1 (+0.53%) 11:47 Today Visa offered sweetened $1.4B for Pismo, Valor says 03/16/23 WeWork nearing deal for 'major' restructuring, Bloomberg says 03/06/23 SoftBank-backed CloudMinds weighing Hong Kong IPO, Bloomberg reports 03/05/23 SoftBank's Arm aims to raise at least $8 billion in U.S. IPO, Reuters reports SFTBY SFTBY SoftBank Group $18.93 / +0.1 (+0.53%) 03/01/23 What You Missed On Wall Street On Wednesday 02/13/23 What You Missed On Wall Street On Monday 02/13/23 What You Missed On Wall Street This Morning 11/18/22 What You Missed On Wall Street On Friday
Syndicate	Aslan Pharmaceuticals files to sell 388.91M ordinary shares for holders 16:40 03/24/23 03/24 16:40 03/24/23 16:40 ASLN Aslan Pharmaceuticals $2.91 / +0.17 (+6.20%) ShowHide Related Items >><< Company News Street Research Earnings ASLN Aslan Pharmaceuticals $2.91 / +0.17 (+6.20%) 07:08 Today Aslan Pharmaceuticals announces anticipated milestones 07:07 Today Aslan Pharmaceuticals expects cash to fund operations throuhg 2Q24 03/10/23 Aslan Pharmaceuticals announces plan to implement ADS ratio change 03/08/23 Aslan Pharmaceuticals to host virtual research day on AA ASLN Aslan Pharmaceuticals $2.91 / +0.17 (+6.20%) 02/27/23 Piper Sandler Aslan Pharmaceuticals price target lowered to $3 from $4 at Piper Sandler 02/27/23 H.C. Wainwright Aslan Pharmaceuticals price target lowered to $4.50 from $7 at H.C. Wainwright 10/28/22 Piper Sandler Aslan Pharmaceuticals ended Q3 with $69M in cash, says Piper Sandler 09/16/22 Piper Sandler Aslan Pharmaceuticals price target raised to $4 from $3 at Piper Sandler ASLN Aslan Pharmaceuticals $2.91 / +0.17 (+6.20%) 07:07 Today Aslan Pharmaceuticals reports Q4 EPS (4c) vs. (3c) last year 10/28/22 Aslan Pharmaceuticals reports Q3 EPS (16c) vs. (12c) last year
Hot Stocks	Berkshire Grey trading halted, news pending 16:40 03/24/23 03/24 16:40 03/24/23 16:40 BGRY Berkshire Grey $1.14 / -0.055 (-4.60%) ShowHide Related Items >><< Company News Street Research Earnings BGRY Berkshire Grey $1.14 / -0.055 (-4.60%) 02/10/23 Berkshire Grey confirms receipt of indication of interest from SoftBank Group 01/26/23 Berkshire Grey and Locus Robotics team on cross-platform robotic automation 10/05/22 Berkshire Grey enters $75M equity purchase agreement with Lincoln Park Capital BGRY Berkshire Grey $1.14 / -0.055 (-4.60%) 08/02/22 Craig-Hallum Berkshire Grey pact with FedEx 'significant catalyst,' says Craig-Hallum 03/30/22 Craig-Hallum Berkshire Grey price target lowered to $8 from $15 at Craig-Hallum BGRY Berkshire Grey $1.14 / -0.055 (-4.60%) 11/14/22 Berkshire Grey lowers FY22 revenue view to $65M-$70M from $70M-$80M 11/14/22 Berkshire Grey reports Q3 EPS (11c), consensus (13c)
Hot Stocks	Eastern Company announces restructuring of COO position » 16:37 03/24/23 03/24 16:37 03/24/23 16:37 EML Eastern Company $19.94 / +0.89 (+4.67%) The Eastern Company… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Events EML Eastern Company $19.94 / +0.89 (+4.67%) 01/26/23 Eastern Company appoints Nick Vlahos as CFO 01/10/23 Eastern Company appoints Mark Hernandez as CEO 10/19/22 Eastern Company confirms sale of Argo EMS business, terms not disclosed 04/25/23 The Eastern Company
Hot Stocks	NuCana: TBA of EPO rules European Patent 2955190 not valid » 16:35 03/24/23 03/24 16:35 03/24/23 16:35 NCNA NuCana $1.25 / -0.19 (-13.19%) NuCana announced that,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings NCNA NuCana $1.25 / -0.19 (-13.19%) 01/23/23 NuCana regains compliance with Nasdaq minimum bid price requirement 01/06/23 NuCana receives Nasdaq notice of non-compliance 10/26/22 NuCana presents data on NUC-3373 at EORTC-NCI-AACR Meeting NCNA NuCana $1.25 / -0.19 (-13.19%) 11/28/22 Citi NuCana price target lowered to $2 from $5 at Citi 09/22/22 Jefferies NuCana price target lowered to $3 from $21 at Jefferies 04/13/22 Truist NuCana price target lowered to $6 from $22 at Truist NCNA NuCana $1.25 / -0.19 (-13.19%) 11/16/22 NuCana reports Q3 EPS (GBP 0.09) vs, (GBP 0.15) last year
Syndicate	Live Ventures files $50M mixed securities shelf 16:35 03/24/23 03/24 16:35 03/24/23 16:35 LIVE Live Ventures $32.21 / -0.795 (-2.41%) ShowHide Related Items >><< Company News Earnings LIVE Live Ventures $32.21 / -0.795 (-2.41%) 01/19/23 Live Ventures acquires Flooring Liquidators for $84M LIVE Live Ventures $32.21 / -0.795 (-2.41%) 02/09/23 Live Ventures reports Q1 EPS 60c vs $2.04 last year 12/15/22 Live Ventures reports Q4 EPS (20c) vs $2.23 last year

Syndicate	Otis Worldwide files automatic mixed securities shelf 16:35 03/24/23 03/24 16:35 03/24/23 16:35 OTIS Otis Worldwide $80.51 / +0.17 (+0.21%) ShowHide Related Items >><< Company News Street Research Earnings OTIS Otis Worldwide $80.51 / +0.17 (+0.21%) 02/27/23 Otis Worldwide appoints Sally Loh as President, Otis China 12/21/22 Otis Worldwide achieves Gold-level TRUE certification for zero waste efforts OTIS Otis Worldwide $80.51 / +0.17 (+0.21%) 02/02/23 Cowen Otis Worldwide price target raised to $95 from $90 at Cowen 02/02/23 Wells Fargo Otis Worldwide price target raised to $82 from $76 at Wells Fargo 01/06/23 Morgan Stanley Otis Worldwide initiated with an Equal Weight at Morgan Stanley 12/01/22 Barclays Otis Worldwide downgraded to Equal Weight from Overweight at Barclays OTIS Otis Worldwide $80.51 / +0.17 (+0.21%) 02/01/23 Otis Worldwide sees FY23 adjusted EPS $3.35-$3.50, consensus $3.44 02/01/23 Otis Worldwide reports Q4 adjusted EPS 75c, consensus 74c 10/26/22 Otis Worldwide cuts FY22 adjusted EPS view to $3.11-$3.15 from $3.17-$3.21 10/26/22 Otis Worldwide reports Q3 EPS 80c, consensus 78c
Syndicate	Aslan Pharmaceuticals files to sell $200M of ordinary shares 16:34 03/24/23 03/24 16:34 03/24/23 16:34 ASLN Aslan Pharmaceuticals $2.91 / +0.17 (+6.20%) ShowHide Related Items >><< Company News Street Research Earnings ASLN Aslan Pharmaceuticals $2.91 / +0.17 (+6.20%) 07:08 Today Aslan Pharmaceuticals announces anticipated milestones 07:07 Today Aslan Pharmaceuticals expects cash to fund operations throuhg 2Q24 03/10/23 Aslan Pharmaceuticals announces plan to implement ADS ratio change 03/08/23 Aslan Pharmaceuticals to host virtual research day on AA ASLN Aslan Pharmaceuticals $2.91 / +0.17 (+6.20%) 02/27/23 Piper Sandler Aslan Pharmaceuticals price target lowered to $3 from $4 at Piper Sandler 02/27/23 H.C. Wainwright Aslan Pharmaceuticals price target lowered to $4.50 from $7 at H.C. Wainwright 10/28/22 Piper Sandler Aslan Pharmaceuticals ended Q3 with $69M in cash, says Piper Sandler 09/16/22 Piper Sandler Aslan Pharmaceuticals price target raised to $4 from $3 at Piper Sandler ASLN Aslan Pharmaceuticals $2.91 / +0.17 (+6.20%) 07:07 Today Aslan Pharmaceuticals reports Q4 EPS (4c) vs. (3c) last year 10/28/22 Aslan Pharmaceuticals reports Q3 EPS (16c) vs. (12c) last year
Periodicals	BridgeBio attracting bigger companies' takeover interest, Bloomberg says » 16:34 03/24/23 03/24 16:34 03/24/23 16:34 BBIO BridgeBio $14.00 / +0.415 (+3.05%) BridgeBio is drawing… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly BBIO BridgeBio $14.00 / +0.415 (+3.05%) 16:00 Today BridgeBio Pharma trading resumes 15:57 Today BridgeBio up 3%, halted for volatility after report on takeover interest 15:54 Today BridgeBio Pharma trading halted, volatility trading pause 03/23/23 BridgeBio announces first patient dosed in Phase 1 trial of BBP-398 with OPDIVO BBIO BridgeBio $14.00 / +0.415 (+3.05%) 03/07/23 BofA Ascendis Pharma has positive read-through from BridgeBio data, says BofA 03/07/23 BofA Tyra Biosciences has positive read-through from BridgeBio data, says BofA 03/07/23 BofA BridgeBio price target raised to $18 from $15 at BofA 03/06/23 Oppenheimer Opco views BridgeBio data as good news for Tyra Biosciences BBIO BridgeBio $14.00 / +0.415 (+3.05%) 02/23/23 BridgeBio reports Q4 EPS (92c), consensus (85c) 11/03/22 BridgeBio reports Q3 EPS (93c), consensus (99c) 08 Mar BBIO BridgeBio $14.00 / +0.415 (+3.05%) 15:56 Today BridgeBio attracting bigger companies' takeover interest, Bloomberg says BBIO BridgeBio $14.00 / +0.415 (+3.05%) 03/08/23 What You Missed On Wall Street On Wednesday 03/08/23 What You Missed On Wall Street This Morning 03/06/23 What You Missed On Wall Street On Monday 03/06/23 What You Missed On Wall Street This Morning
Hot Stocks	Hepsiburada receives Nasdaq notification over minimum bid price » 16:33 03/24/23 03/24 16:33 03/24/23 16:33 HEPS Hepsiburada $1.13 / +0.025 (+2.26%) Hepsiburada announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News HEPS Hepsiburada $1.13 / +0.025 (+2.26%) 02/15/23 Hepsiburada says nine cross-dock points impacted by recent earthquake 02/01/23 Hepsiburada regains Nasdaq listing compliance 01/03/23 Nilhan Onal Gokcetekin begins tenure as Hepsiburada CEO 11/04/22 Hepsiburada receives Nasdaq notification over minimum bid price
Syndicate	Hanmi Financial files automatic mixed securities shelf 16:33 03/24/23 03/24 16:33 03/24/23 16:33 HAFC Hanmi Financial $18.68 / +0.15 (+0.81%) ShowHide Related Items >><< Company News Street Research Earnings HAFC Hanmi Financial $18.68 / +0.15 (+0.81%) 10/26/22 Hanmi Financial partners with HoneyBee for Choice Checking account HAFC Hanmi Financial $18.68 / +0.15 (+0.81%) 05/18/22 DA Davidson Hanmi Financial cut to Neutral at DA Davidson on expected underperformance 05/18/22 DA Davidson Hanmi Financial downgraded to Neutral from Buy at DA Davidson HAFC Hanmi Financial $18.68 / +0.15 (+0.81%) 01/24/23 Hanmi Financial reports Q4 EPS 93c, consensus 83c 10/25/22 Hanmi Financial reports Q3 EPS 89c, consensus 77c

Events

Earnings calls, analyst events, roadshows and more

AAP ...
2023-03-26 at 00:00

Shop Talk Conferences

Mandalay Bay, Las Vegas, NV
FIVN ...
2023-03-27 at 00:00

Piper Sandler Hosted Company Meetings at 2023 Enterprise Connect Conferences

Orlando, FL
2023-03-27 at 00:00

2023 Enterprise Connect Conference & Expo Conferences

Gaylord Palms, Orlando, FL
2023-03-27 at 00:00

Gulf Coast Casino Bus Tour Conferences

Southeast
2023-03-27 at 00:00

Shop Talk Conferences

Mandalay Bay, Las Vegas, NV
AUDC ...
2023-03-27 at 00:00

Needham Hosted Company Meetings at 2023 Enterprise Connect Conference Conferences

Orlando, FL
2023-03-27 at 00:00

KeyBanc Hosted Company Meetings at Enterprise Connect Conferences

Orlando, FL
NYXH
2023-03-27 at 00:00

Nyxoah Firm Sponsored Meetings

Virtual Meeting
SGHC
2023-03-27 at 00:00

Super Group Firm Sponsored Meetings

Virtual Meeting
GSHD
2023-03-27 at 00:00

Goosehead Insurance Firm Sponsored Meetings

Los Angeles/San Francisco, CA

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	MGRX X MGRX Mangoceuticals IPO Managers: Boustead Priced at: $4.00 1.25M Shares
Tues	KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs, JPMorgan, Morgan Stanley Priced at: $161.33 2.48M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	BANL X BANL CBL International IPO Managers: Pacific Century Priced at: $4.00 3.325M Shares
Thurs	ETNB X ETNB 89bio Secondary Managers: BofA, SVB Securities & Evercore ISI Priced at: $16.25 16.92M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Field Trip Health announces posting on the OTC Market

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access